Pulmuone Corporate

KOSE:A017810 Lagerbericht

Marktkapitalisierung: ₩423.6b

Pulmuone Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Pulmuone wird ein jährliches Gewinn- und Umsatzwachstum von 51% bzw. 4.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 49.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 16.9% betragen.

Wichtige Informationen

51.0%

Wachstumsrate der Gewinne

49.4%

EPS-Wachstumsrate

Food Gewinnwachstum16.2%
Wachstumsrate der Einnahmen4.8%
Zukünftige Eigenkapitalrendite16.9%
Analystenabdeckung

Low

Zuletzt aktualisiert11 Jul 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

At ₩11,410, Is Pulmuone Corporate (KRX:017810) Worth Looking At Closely?

Nov 15
At ₩11,410, Is Pulmuone Corporate (KRX:017810) Worth Looking At Closely?

Pulmuone (KRX:017810) Use Of Debt Could Be Considered Risky

Jul 26
Pulmuone (KRX:017810) Use Of Debt Could Be Considered Risky

Pulmuone's (KRX:017810) Returns Have Hit A Wall

Jun 12
Pulmuone's (KRX:017810) Returns Have Hit A Wall

Pulmuone Corporate (KRX:017810) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

May 24
Pulmuone Corporate (KRX:017810) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

Market Participants Recognise Pulmuone Corporate's (KRX:017810) Revenues Pushing Shares 31% Higher

May 24
Market Participants Recognise Pulmuone Corporate's (KRX:017810) Revenues Pushing Shares 31% Higher

We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Mar 27
We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Is Now An Opportune Moment To Examine Pulmuone Co., Ltd. (KRX:017810)?

Apr 13
Is Now An Opportune Moment To Examine Pulmuone Co., Ltd. (KRX:017810)?

There Are Reasons To Feel Uneasy About Pulmuone's (KRX:017810) Returns On Capital

Mar 26
There Are Reasons To Feel Uneasy About Pulmuone's (KRX:017810) Returns On Capital

Pulmuone Co., Ltd. (KRX:017810) Is Yielding 0.6% - But Is It A Buy?

Mar 08
Pulmuone Co., Ltd. (KRX:017810) Is Yielding 0.6% - But Is It A Buy?

Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

Feb 18
Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

Does Pulmuone's (KRX:017810) Share Price Gain of 57% Match Its Business Performance?

Jan 31
Does Pulmuone's (KRX:017810) Share Price Gain of 57% Match Its Business Performance?

Based On Its ROE, Is Pulmuone Co., Ltd. (KRX:017810) A High Quality Stock?

Jan 13
Based On Its ROE, Is Pulmuone Co., Ltd. (KRX:017810) A High Quality Stock?

When Should You Buy Pulmuone Co., Ltd. (KRX:017810)?

Dec 26
When Should You Buy Pulmuone Co., Ltd. (KRX:017810)?

Key Things To Watch Out For If You Are After Pulmuone Co., Ltd.'s (KRX:017810) 0.6% Dividend

Dec 08
Key Things To Watch Out For If You Are After Pulmuone Co., Ltd.'s (KRX:017810) 0.6% Dividend

These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Nov 20
These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Gewinn- und Umsatzwachstumsprognosen

KOSE:A017810 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (KRW Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20263,500,40077,200N/A208,0001
12/31/20253,309,60064,100N/A203,9001
12/31/20243,142,75043,95025,300188,0502
9/30/20243,157,98414,29541,449151,744N/A
6/30/20243,070,3858,40422,365128,797N/A
3/31/20243,032,7228,85739,242156,538N/A
12/31/20232,993,4689,36566,157193,580N/A
9/30/20232,958,921-28,79948,350172,460N/A
6/30/20232,967,237-27,38627,389161,103N/A
3/31/20232,917,752-29,683-29,283116,591N/A
12/31/20222,838,304-29,957-54,52992,256N/A
9/30/20222,752,559-1,547-96,461102,996N/A
6/30/20222,659,691-786-97,638104,899N/A
3/31/20222,588,871-3,820-114,780105,871N/A
12/31/20212,518,8965,326-104,573118,483N/A
9/30/20212,457,29312,577-63,175120,492N/A
6/30/20212,399,10812,989-78,237101,972N/A
3/31/20212,329,17517,542-26,907119,900N/A
12/31/20202,311,20014,880-45,707103,961N/A
9/30/20202,339,35315,663-61,55384,400N/A
6/30/20202,362,83913,047-33,498108,378N/A
3/31/20202,394,78015,121-59,80386,106N/A
12/31/20192,381,4512,092-41,90085,410N/A
9/30/20192,341,49912,708-8,649107,434N/A
6/30/20192,300,88215,531-17,70974,623N/A
3/31/20192,276,08515,987-14,11677,653N/A
12/31/20182,271,97320,448-37,88659,291N/A
9/30/20182,257,20924,953-47,93242,099N/A
6/30/20182,244,98629,473N/A53,537N/A
3/31/20182,222,75035,628N/A45,481N/A
12/31/20172,195,65838,506N/A62,648N/A
9/30/20172,182,18242,149N/A59,331N/A
6/30/20172,134,20636,862N/A47,607N/A
3/31/20172,089,07820,413N/A60,222N/A
12/31/20162,030,67318,595N/A57,937N/A
9/30/20161,963,63820,184N/A54,603N/A
6/30/20161,917,45112,666N/A66,996N/A
3/31/20161,874,81319,773N/A38,453N/A
12/31/20151,846,48820,319N/A106,415N/A
9/30/20151,822,00458,819N/A121,686N/A
6/30/20151,789,62760,187N/A118,992N/A
3/31/20151,743,29057,841N/A144,260N/A
12/31/20141,678,09455,023N/A82,174N/A
9/30/20141,615,684-5,251N/A78,694N/A
6/30/20141,565,074-3,726N/A100,735N/A
3/31/20141,538,641-6,555N/A99,135N/A
12/31/20131,521,708-6,299N/A111,377N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: A017810Das prognostizierte Gewinnwachstum (51% pro Jahr) liegt über der Sparquote (2.7%).

Ertrag vs. Markt: A017810Die Erträge des Unternehmens (51% pro Jahr) werden voraussichtlich schneller wachsen als der Markt KR (29.2% pro Jahr).

Hohe Wachstumserträge: A017810Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: A017810Die Einnahmen des Unternehmens (4.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt KR (9.1% pro Jahr).

Hohe Wachstumseinnahmen: A017810Die Einnahmen des Unternehmens (4.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: A017810Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (16.9%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y